01.07.2024 08:11:48 - dpa-AFX: *AZN : LYNPARZA AND IMFINZI COMBINATION RECOMMENDED FOR APPROVAL IN EU BY CHMP FOR RECURRENT ENDOMETRIAL CANCER

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
ASTRAZENECA PLC DL-,25 886455 Xetra 150,600 12.08.24 16:54:39 +1,800 +1,21% 150,350 150,600 148,750 148,800

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH